Sunstar Americas Inc. (SAI) issued a voluntary recall of specific lots of chlorhexidine gluconate 0.12% oral rinse with an expiration date between 6/30/2022 – 9/30/2022 due to possible bacterial contamination...
Some metformin hydrochloride extended-release (ER) products, including brand-name Fortament and Glumetza, may contain low concentrations of a probable human carcinogen called N-nitrosodimethylamine (NDMA).
FDA issued a Drug Safety Communication recommending against non-steroidal anti-inflammatory drug (NSAID) use in pregnant women at 20 weeks or later due to serious and rare kidney complications in an...
FDA recently issued a MedWatch alert warning consumers about serious harm with diphenhydramine when taken in amounts exceeding the recommended dose. The warning is in response to recent reports of...
Acella LLC is recalling specific lots of 15 mg and 120 mg levothyroxine (T4) and liothyronine (T3) thyroid tablets, USP (NP Thyroid) due to sub potency identified during testing.
Certain hand sanitizers labeled with ethanol (ethyl alcohol) or isopropyl alcohol as the primary ingredient have been found to contain subpotent concentrations of these ingredients or to contain methanol or...
Ferring Pharmaceuticals US is recalling the following desmopressin nasal spray products for possible superpotency identified during routine product testing.
Manufacturers are being required by the FDA to add recommendations about naloxone to prescribing information for all opioids, including buprenorphine and methadone which are used to treat opioid use disorder...
Two lot numbers of dexmedetomidine hydrochloride (Precedex) 200 mcg/50 ml injection have been recalled by Fresenius Kabi USA due to the potential of lidocaine contamination.
FDA released a safety alert regarding the possible reduced antiviral activity of remdesivir when administered concomitantly with hydroxychloroquine sulfate or chloroquine phosphate.
